Ventricular Response to Dobutamine Stress CMR Is a Predictor for Outcome in Fontan Patients

JACC Cardiovasc Imaging. 2019 Feb;12(2):368-370. doi: 10.1016/j.jcmg.2018.07.025. Epub 2018 Oct 17.

Authors

Eva van den Bosch, Sjoerd S M Bossers, Daniëlle Robbers-Visser, Eric Boersma, Jolien W Roos-Hesselink, Hans M P J Breur, Nico A Blom, Lucia J M Kroft, Miranda M Snoeren, Livia Kapusta, Willem A Helbing

PMID: 30343077
DOI: 10.1016/j.jcmg.2018.07.025

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Cardiotonic Agents / administration & dosage*
Child
Dobutamine / administration & dosage*
Female
Fontan Procedure* / adverse effects
Fontan Procedure* / mortality
Heart Defects, Congenital / diagnostic imaging*
Heart Defects, Congenital / mortality
Heart Defects, Congenital / physiopathology
Heart Defects, Congenital / surgery*
Humans
Magnetic Resonance Imaging / methods*
Male
Predictive Value of Tests
Progression-Free Survival
Risk Factors
Time Factors
Ventricular Function, Left*
Ventricular Function, Right*

Substances

Cardiotonic Agents
Dobutamine